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Abstract
Background: MicroRNAs (miRNA) are a novel class of small, non-coding, gene regulatory RNA
molecules that have diverse roles in a variety of eukaryotic biological processes. High-throughput
detection and differential expression analysis of these molecules, by microarray technology, may
contribute to a greater understanding of the many biological events regulated by these molecules.
In this investigation we compared two different methodologies for the preparation of labelled
miRNAs from mouse CNS tissue for microarray analysis. Labelled miRNAs were prepared either
by a procedure involving linear amplification of miRNAs (labelled-aRNA) or using a direct labelling
strategy (labelled-cDNA) and analysed using a custom miRNA microarray platform. Our aim was
to develop a rapid, sensitive methodology to profile miRNAs that could be adapted for use on
limited amounts of tissue.
Results: We demonstrate the detection of an equivalent set of miRNAs from mouse CNS tissues
using both amplified and non-amplified labelled miRNAs. Validation of the expression of these
miRNAs in the CNS by multiplex real-time PCR confirmed the reliability of our microarray
platform. We found that although the amplification step increased the sensitivity of detection of
miRNAs, we observed a concomitant decrease in specificity for closely related probes, as well as
increased variation introduced by dye bias.
Conclusion: The data presented in this investigation identifies several important sources of
systematic bias that must be considered upon linear amplification of miRNA for microarray analysis
in comparison to directly labelled miRNA.
Background
MicroRNAs (miRNA) are an evolutionarily conserved,
large new class of ~22 nucleotide (nt) long, gene regula-
tory RNA molecules that are involved in silencing mRNA
transcripts through sequence-specific hybridization to 3'
UTRs of mRNA molecules [1]. In plants, gene silencing is
mediated primarily through RNA interference where the
miRNAs are fully complementary to their mRNA targets.
In contrast, animal miRNAs are only partially comple-
mentary to their targets, and silence gene expression by
mechanisms that involve the co-localization of miRNAs
and miRNA targets to cytoplasmic foci known as P-bodies
as well as degradation of target mRNA [2-8]. Concur-
rently, a role for miRNAs in proliferative diseases has also
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been suggested, specifically during cancers, where a large
number of miRNAs appear to be de-regulated in primary
human tumours [9-13]. The current paradigm that miR-
NAs represent a new layer of gene regulation has gener-
ated much interest in this field. Thus, detection of
miRNAs, their expression analysis, and identification of
potential regulatory targets (cognate mRNA) are burgeon-
ing areas of research.
The most commonly used technique to detect miRNAs is
a Northern blot. A Northern blot can reliably profile the
transcription of miRNAs and has often been used in the
analysis of developmental and tissue-specific expression
patterns [18-22]. However, this method is also limited
because it cannot be used for the simultaneous monitor-
ing of hundreds of miRNAs and requires substantial
amounts of sample. As such, microarray technology pro-
vides a promising alternative to the Northern blot as
numerous miRNAs can be analyzed at once with relatively
minimal amount of initial RNA investment [23].
A number of recent reports have outlined ways in which
microarray technology can be used to detect and profile
the expression of miRNAs isolated from cells or tissues
[15,16,24-35]. These reports can be classified into several
categories based on variations in the methodologies
employed to prepare labelled-targets for hybridization.
Firstly, there are reports in which the mature ~22 nt long
miRNAs have been directly labelled and used for hybridi-
zation [24,28,30,33-35]. Secondly, reports in which
cDNA synthesized from the reverse transcription of adap-
tor-ligated miRNAs have served as the labelled miRNA tar-
gets for hybridization [15,26,29,31]. In this category,
either modified bases capable of binding or already con-
taining a label have served as nucleotides for cDNA syn-
thesis during reverse transcription, or the adaptor-specific
primers used for reverse transcription were the source of
the label for the miRNA. Thirdly, there are reports that are
similar to the second category except that the cDNA is PCR
amplified prior to serving as the targets for hybridization
[16,25,27,32]. In this category, the miRNAs were initially
ligated to specific adaptors at both the 3' and 5' ends.
Additionally, there are other novel methods that are pres-
ently being developed to measure miRNA expression
[16,36].
From the survey of published reports it is apparent that
miRNA microarray analysis is a growing field but it is also
in its infancy and there is a need for detailed comparison
of data obtained from different methodologies before a
consensus is drawn on the ideal method(s) for labelled
target preparation. Based on this premise and our ultimate
goal to analyze very limited amounts of miRNA obtained
from procedures such as laser capture microdissection, we
evaluated two different methods for the preparation of
labelled-targets; targets prepared from amplified and non-
amplified miRNA. The amplification of limited amounts
of RNA prior to microarray analysis is a common strategy
for longer transcripts; however, less is known about the
effects of amplification of miRNAs for microarray analy-
sis.
The primary aim of this investigation was to optimize a
simple and dependable labelling protocol for microarray
analysis of miRNAs from enriched mixtures of low molec-
ular weight (LMW) RNA without gel purification that
would have potential for use when the starting quantity of
RNA is low. Our objectives for this investigation were; to
determine whether the sensitivity of detection of miRNAs
can be increased by amplification as compared to a direct
labelling methodology, and to determine whether an
accurate representation of the original miRNA population
is retained following amplification.
Results
Construction and specificity of the miRNA microarray
A total of 557 unique oligonucleotide probes to the
majority of metazoan miRNAs in the miRNA registry
(Release 5.0) [37] as well as to mature miRNA sequences
from published literature at the time the project was initi-
ated, were spotted onto glass slides in duplicate grids (See
Additional File 1). Probes are in the same orientation as
the miRNAs themselves. An initial evaluation showed that
modifications of the probes to covalently link them to the
slide surface was not necessary in order to allow high sig-
nal intensities with our choice of surface chemistry, epox-
ide coated slides from Corning (data not shown). We did
however find that the addition of a 15 nucleotide poly(T)
tract at the 5' end of the probes increased signal intensi-
ties, possibly by reducing steric hindrance due to the prox-
imity of the short probe sequences to the slide surface.
We tested the specificity of the probes on the microarray
by designing matched and mismatched probes and com-
paring the signal intensities after hybridization with
labelled miRNAs. For this, an array was constructed on
which oligonucleotide probes for two different miRNAs
were spotted, additional probes were then designed
around these sequences containing increasing number of
nucleotide mismatches. All probes were spotted in quad-
ruplicate on each slide. Along with probe specificity, the
relationship between the 3' and 5' location of the mis-
matches was also assayed. At most, there were 7 nucle-
otide mismatches originating at either the 3' or 5' end of a
probe; probe sequences are provided in Table 1. Comple-
mentary, synthetic miRNA targets were then hybridized to
these arrays under standard conditions (overnight incuba-
tion at 50°C). The results are displayed in Figure 1. We
found that mismatches at the 5' end of the probes for the
miRNA sequences we looked at were tolerated to a signif-BMC Biotechnology 2006, 6:47 http://www.biomedcentral.com/1472-6750/6/47
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icantly greater extent than those at the 3' end. In both
cases, up to 2 mismatches at the 5' end did not result in
any significant decrease in hybridization, with up to 4
mismatches giving hybridization signal above back-
ground. Signal was significantly reduced upon hybridiza-
tion of both types of miRNAs to probes containing only
one or two mismatches at the 3' end; signal was less than
half that of perfectly matched probe and target. Signal was
not above background when 3 or more mismatches were
located at the 3' end of the probe. We also varied the
hybridization temperature (42, 46, 55°C) to monitor the
effect on array specificity, however, little change in specif-
icity was apparent at the different temperatures assayed.
From this data we do not expect the microarray to consist-
ently resolve miRNAs that have only one or two base dif-
ferences, especially towards the 5' end. The majority of
identified miRNAs, however, differ from each other by 5
or more mismatches and so in most of the cases we can
confidently discriminate between different miRNAs [25].
Closely related miRNAs may require further analysis by
other means to accurately measure their levels of expres-
sion [38,39].
Development of a linear amplification labeling method for 
preparation of antisense miRNA targets
We developed a method to prepare and label miRNA tar-
gets using a linear amplification procedure in which an
antisense-labelled target is produced. RNA is polyade-
nylated and used as a template for cDNA production.
After second strand synthesis a T7 linear amplification
protocol was used to produce antisense RNA that was con-
jugated with fluorescent dyes prior to hybridization to
microarrays (See Additional File 2). Using 100 ng of LMW
RNA as starting material a strong fluorescent signal was
detected, with some spots close to saturation, and we went
on to use this labelling methodology to test a range of
concentrations of miRNA starting material to determine
the sensitivity threshold, and the dynamic range, for
detection of our microarray, after target amplification.
This was done by titration of a commercially synthesized
miRNA and performing linear amplifications on the titra-
tions to generate amplified labelled-targets (labelled-
Table 1: Sequences of the miRNA probes spotted on the specificity microarrays
miRNA annotationa Probe sequence 5'-3' Number of mismatches
mmu-miR-124a [perfect] ttttttttttttttttaaggcacgcggtgaatgcc 0
mmu-miR-124a [5'-1] tttttttttttttttcaaggcacgcggtgaatgcc 1
mmu-miR-124a [5'-2] tttttttttttttttcacggcacgcggtgaatgcc 2
mmu-miR-124a [5'-3] tttttttttttttttcacgacacgcggtgaatgcc 3
mmu-miR-124a [5'-4] tttttttttttttttcacgacccgcggtgaatgcc 4
mmu-miR-124a [5'-5] tttttttttttttttcacgaccctcggtgaatgcc 5
mmu-miR-124a [5'-6] tttttttttttttttcacgaccctcgttgaatgcc 6
mmu-miR-124a [5'-7] tttttttttttttttcacgaccctcgtttaatgcc 7
mmu-miR-124a [3'-1] ttttttttttttttttaaggcacgcggtgaatgcg 1
mmu-miR-124a [3'-2] ttttttttttttttttaaggcacgcggtgaatccg 2
mmu-miR-124a [3'-3] ttttttttttttttttaaggcacgcggtggatccg 3
mmu-miR-124a [3'-4] ttttttttttttttttaaggcacgcgggggatccg 4
mmu-miR-124a [3'-5] ttttttttttttttttaaggcacgccggggatccg 5
mmu-miR-124a [3'-6] ttttttttttttttttaaggcaccccggggatccg 6
mmu-miR-124a [3'-7] ttttttttttttttttaagccaccccggggatccg 7
mmu-miR-213 [perfect] tttttttttttttttaccatcgaccgttgattgtacc 0
mmu-miR-213 [5'-1] ttttttttttttttttccatcgaccgttgattgtacc 1
mmu-miR-213 [5'-2] ttttttttttttttttcgatcgaccgttgattgtacc 2
mmu-miR-213 [5'-3] ttttttttttttttttcgagcgaccgttgattgtacc 3
mmu-miR-213 [5'-4] ttttttttttttttttcgagcgagcgttgattgtacc 4
mmu-miR-213 [5'-5] ttttttttttttttttcgagcgagcgttgtttgtacc 5
mmu-miR-213 [5'-6] ttttttttttttttttcgagcgagcggtgtttgtacc 6
mmu-miR-213 [5'-7] ttttttttttttttttcgagcgagcggggtttgtacc 7
mmu-miR-213 [3'-1] tttttttttttttttaccatcgaccgttgattgtacg 1
mmu-miR-213 [3'-2] tttttttttttttttaccatcgaccgttgattgttcg 2
mmu-miR-213 [3'-3] tttttttttttttttaccatcgaccgttggttgttcg 3
mmu-miR-213 [3'-4] tttttttttttttttaccatcgaccgctggttgttcg 4
mmu-miR-213 [3'-5] tttttttttttttttaccatcgatcgctggttgttcg 5
mmu-miR-213 [3'-6] tttttttttttttttaccatctatcgctggttgttcg 6
mmu-miR-213 [3'-7] tttttttttttttttaccatgtatcgctggttgttcg 7
a. The numbers in the square parenthesis represent the location and number of mismatches on the probes.
The nucleotide bases in bold represent the substitutions that were made to the original miRNA sequence.BMC Biotechnology 2006, 6:47 http://www.biomedcentral.com/1472-6750/6/47
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aRNA). The labelled-targets were then hybridized to arrays
that had complimentary probes printed in quadruplicate.
Unrelated miRNAs and probes with between 1 and 7
nucleotide mismatches were printed as specificity and
hybridization controls. The signal/background ratios for
hybridizations using between 150 fmoles to 1.5 amoles of
miRNA target was calculated and shown in Figure 2. Back-
ground was determined as an average of intensities from
spots containing an unrelated control miRNA probes. We
found that 150 amoles of miRNA can be reliably ampli-
fied and detected by our microarray. We detected signal
on the probes even after amplification of only 1.5 amoles
of miRNA, but we found that as we lowered the quantity
of miRNA, the signal from mismatched probes increased
relative to the perfectly matched probes. We calculated
this reduction in specificity based on the ability to dis-
criminate between hybridization to perfectly matched
probes, and those containing 5 mismatches, and plotted
these values on Figure 2. We concluded that errors are
introduced into the miRNA targets during the amplifica-
tion procedure resulting in loss of hybridization specifi-
city. The microarray had a broad range of detection of
approximately three orders of magnitude.
Confirmation of the validity of miRNA expression profiles 
following amplification
We went on to determine whether amplification affects
the proportional representation of miRNA species identi-
fied from a complex mixture, in comparison to another
method that does not include an amplification step.
Expression profiles for miRNAs isolated from brain tissue
and amplified using the T7 linear amplification method
as previously described were compared with profiles gen-
erated using antisense, tagged-cDNA hybridized to the
array and signal amplified by dendrimer technology (See
Specificity of the complementary miRNA microarray probes Figure 1
Specificity of the complementary miRNA microarray probes. Synthetic miRNA targets were hybridized to arrays 
containing probes that had increasing number of nucleotide mismatches at either the 3' or 5' ends.
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Additional File 2). The starting population of LMW RNA
for all experimental procedures was prepared from total
mouse brain as a single batch to ensure reproducibility.
Each labelling reaction used between 100 and 250 ng of
this LMW RNA as outlined in the methods section. The
only variable factor was the labelled miRNA preparation
technique employed. Total RNA consists of ~0.1% miRNA
and the miRNA isolation technique we used results in a 10
fold enrichment of small RNAs (less than 200 nt long)
and so between 1 ng and 2.5 ng of miRNA was used in
each labelling reaction.
Significant signal was detectable on negative control
spots, as well as to miRNA probe sequences from species
other than mice, and not present in the mouse genome.
We adjusted the intensity values for the spots to take this
into account; an average signal intensity value was calcu-
lated for each slide from these control spots, and this was
then subtracted from all spots on the array to determine
net signal intensities. In contrast, hybridizations of target
LMW RNA prepared without an amplification step
(labelled-cDNA) had lower signal intensities, but little
detectable non-specific hybridization to control spots; in
this case the background correction step was omitted. The
detection limit for miRNA labelled by the direct labelling
technique was approximately 1.5 fmoles and the detec-
tion range was approximately 2.5 orders of magnitude as
determined by serial dilution, labelling and hybridization
of the synthetic miRNA (data not shown).
Individual miRNAs were then scored as being present or
absent based on the presence of a reproducible signal in
three replica hybridizations, for each of the labelling tech-
niques evaluated. A representative scatter plot illustrating
this data is shown in Figure 3. We determined that a core
group of 100 (~18%) spots on the array were scored as
present when either of the target labelling techniques was
used. In addition, 22 miRNAs were reproducibly detected
on our array only when cDNA labelled targets were used,
with a further 23 different miRNAs only with the aRNA
labelled targets. The correlation coefficients (R2) for aRNA
labelled targets versus cDNA labelled targets through
repeated measurements were low, 0.58 ± 0.15 (n = 5).
However, we concluded that in general, the two target
Detection range of miRNAs by the linear-amplification strategy Figure 2
Detection range of miRNAs by the linear-amplification strategy. A synthetic miRNA (miR-124a) was titrated, linear 
amplified, and hybridized to the arrays. Signal to background ratio and specificity of binding of the miRNA is shown. The 
amount of miRNA that can be reliably amplified and detected by the microarray is denoted with an asterisk.
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labelling techniques evaluated show a high degree of
reproducibility in regards to the miRNAs scored as present
by both methods. A plot of sensitivity and specificity for
each labelling method is provided in Figure 4. Although
we found that the sensitivity of detection for amplified
miRNAs was at least one log higher than for direct labelled
miRNAs using labelling of synthetic miRNAs i.e. 150
amols for amplified miRNAs versus 1.5 fmols for directly
labelled miRNAs, this was not the case in this experiment
using total LMW RNA as starting material. Sensitivity and
specificity measurements were in this case very similar
when either labelling method was used. We concluded
that the decrease in specificity observed when starting
with less abundant miRNAs, 150 amoles or lower, as
recorded in Figure 2, contributed to the high non-specific
hybridization signals that we observed using amplified
RNA. This high background signal effectively masked any
increase in sensitivity that might have resulted from
amplification.
The expression profile of these 145 miRNAs is illustrated
in Figure 5 by a heat map of signal intensities of miRNAs
determined to be present in mouse brain by hybridization
of each of the labelled targets with our miRNA microar-
rays. At least 95 of the 145 miRNA sequences detected by
either labelling methodology, using our array, were pre-
dicted to be expressed in mouse tissues [37]. This number
represents approximately two thirds of the miRNAs esti-
mated to be expressed in mouse tissues from information
in the miRNA registry (Release 5.0). Significant tissue tro-
pism has been associated with many miRNAs and we
would therefore not expect to detect all mouse miRNAs in
brain tissue. A comparison with previous literature on tis-
sue tropism of miRNA expression shows a high degree of
correlation for brain expressed miRNA profiles obtained
using our miRNA microarrays to those obtained by North-
ern blotting. In particular, comparison with the compre-
hensive study by Sempere et al. showed 79% similarity in
the miRNAs assayed and called as present in mouse brain
A representative correlation scatter plot of the normalized signal intensities for the labelled-aRNA versus the directly labelled- cDNA Figure 3
A representative correlation scatter plot of the normalized signal intensities for the labelled-aRNA versus the 
directly labelled-cDNA. Open circles represent miRNAs identified by both techniques when all spots having normalized 
intensities less than 10 were scored as absent.
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tissue [22]. The majority of the remaining 21% were of
low intensity and may not have been detectable by North-
ern Blot.
Validation of microarray data by qRT-PCR
A third method, qRT-PCR was used for independent vali-
dation of miRNA microarray data for the relative expres-
sion of miRNAs in mouse brain [39]. This method has
been determined to be quantitative and sensitive; it
requires as little as 50–100 ng of total cellular RNA as
starting material and is specific enough to allow for dis-
crimination between miRNAs differing by a single nucle-
otide. We determined the dynamic range of the qRT-PCR
assay was from 1.5 pmoles to 1.5 amoles for miRNAs
using a dilution series of the synthetic miRNA previously
described.
In total, 157 of the miRNAs probes on the microarray
were validated using this assay. Positive (miR-16, let-7a)
and negative (ath-miR-159a, cel-miR-2, cel-lin-4) controls
used in the qRT-PCR assay were used to assign Ct cut-off
values to assign present or absent calls for each miRNA.
The negative control miRNAs represent miRNAs not
expressed in mouse tissue and we determined the Ct val-
ues for these probes to be on average >30 for an input
amount of 20 ng LMW RNA. MiRNAs scored as either
present (Ct<27) or absent were then compared with
microarray data; 75 of the miRNAs chosen for validation
were also scored as being present by microarray analysis
and many of these are indicated in Figure 5 for compari-
son. A direct comparison between all the probes validated
by qRT-PCR and by microarray for both types of target
labelling attempted are concisely summarised in Figure 6.
Sensitivity and specificity plot of detection of amplified RNA targets and labelled cDNA targets versus the detection threshold Figure 4
Sensitivity and specificity plot of detection of amplified RNA targets and labelled cDNA targets versus the 
detection threshold. Sensitivity was determined by – number of true positives/(number of true positives + number of false 
negatives) for a number of detection thresholds using the Taqman® results for comparison. Specificity was similarly calculated 
as – number of true negatives/(number of true negatives + number of false positives). ▲ denotes labelled-aRNA; ■ denotes 
labelled-cDNA; ---- denotes specificity; — denotes sensitivity.
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Heat map of signal intensities from miRNAs that were similarly identified by both types of labelling techniques Figure 5
Heat map of signal intensities from miRNAs that were similarly identified by both types of labelling tech-
niques.(†) Represents miRNAs that are no longer listed in the miRNA registry however present on the custom microarray. 
(‡) Represents miRNA-like elements from references 41 and 47. We scored TaqMan detected miRNA probes as present using 
the following criteria. Ath-miR-159a, cel-lin-4, and cel-miR-2 were used as the negative controls (Ct ~30–35). The Ct values 
used to determine +, ++, +++ expression patterns are as follows: +++ – 15–18; ++ – 18 – 21; + – 21–27;BMC Biotechnology 2006, 6:47 http://www.biomedcentral.com/1472-6750/6/47
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The qRT-PCR assay proved to be the most sensitive
method for the detection of miRNAs with 88 being posi-
tively detected in comparison to the microarray; 75 miR-
NAs detected with the cDNA labelled targets and 67 for
the amplified targets. Amplification of miRNAs, in this
case, did not result in increased sensitivity for low abun-
dance miRNAs; probably due to the high background
when using the amplified target which masked low inten-
sity signals. The high background is likely due to non-spe-
cific hybridization of incomplete reverse transcription, or
template-independent, products produced during the
amplification steps that bind with less specificity than
their full-length counterparts [31,40].
With the exception of miRNAs not scored as present by
microarray analysis, the results obtained from each of the
methods evaluated were remarkably similar. Only 2 miR-
NAs were scored as present by microarray analysis using
targets labelled by either the amplification or direct label-
ling techniques but not by the qRT-PCR assay. In turn,
these 2 miRNAs had intensities that were very close to the
cut-off values for the scoring of miRNAs as being present
based on array signals; in fact 61 miRNAs were similarly
scored as present by each method showing a high degree
of agreement between the three methods evaluated.
We concluded from these results that although the sensi-
tivity of microarray detection was lower than qRT-PCR,
the accuracy of miRNA detection, however, was compara-
ble within the detection range of the arrays. In addition,
we found that the amplification step did not significantly
alter the proportional representation of miRNAs in vivo,
especially for those miRNAs present in high abundance. It
is readily apparent from the expression map that the most
abundant miRNAs, including brain specific or enriched
miRNAs, miR-124a-1, -9-1, -9*-1, -127, -136, -138-1, -
149, -154, -218-1, -219-1, -222, -125a, -125b-1, -128a, -
26a-1, -29a, -29b-1, -30c-1, and -34a were equally identi-
fied by both types of microarray labelling techniques.
Amongst the abundant miRNAs identified, detection of
miR-124a-1 was especially important as it is often cloned
at very high frequencies in the brain [18,25,41]. Further-
more, miR-124a-1 has been known to down-regulate
approximately 174 genes in transfected HeLa cells and in
the process alters the entire transcriptome to a neuronal-
like mRNA profile [42].
Dye bias associated with amplification and direct labelling 
methods
Dye bias is a contributing factor to technical variation
seen between replicas in microarray experiments; this is
the appearance of consistently brighter signals for individ-
ual targets in either the green or red channel when there
are no differences in expression between the two. We were
interested to examine whether the amplification proce-
dure in particular contributed to this effect in the analysis
of miRNAs by our microarrays. We performed hybridiza-
tions to 8 microarrays using a single batch of LMW RNA
prepared from mouse brain. The LMW RNA was split into
aliquots, and either amplified for labelled-aRNA or direct-
labelled for cDNA. For each technique evaluated, half of
the RNA was then labelled with either the red or green dye
Venn diagram to illustrate miRNAs detected by TaqMan® MiRNA Assay quantification and miRNA microarray analysis Figure 6
Venn diagram to illustrate miRNAs detected by TaqMan® MiRNA Assay quantification and miRNA microarray analysis.
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and aliquots hybridized to arrays (n = 6). An ANOVA
analysis to estimate the variation introduced by the dye
and the slide (technical replication) was performed. The
results are illustrated in Figure 7. It was apparent from the
results that the slide-to-slide variation is similar for each
method, but that the variation introduced by the dye was
significantly larger for the targets prepared as labelled-
aRNA than for the direct-labelled targets.
The dye bias in favour of amplified targets may be due to
the variability of incorporation kinetics and quenching
susceptibilities of modified dNTPs in the amplification
reactions, thus altering fluorescent signals [43]. Normali-
zation by lowess smoothing did not effectively remove
dye bias from these self-self hybridizations. In contrast,
the significantly lower dye bias for labelled-cDNA may be
due to the dendrimer geometry which permits equal spac-
ing between adjacent dye molecules thus preventing
energy transfer and other types of quenching interactions
which often reduce fluorescent signal [44]. Furthermore,
each cDNA transcript binds a single dendrimer and each
dendrimer has a predetermined number fluorescent mol-
ecules. Cy3-labelled dendrimers have on average of 250
fluorescent molecules per dendrimer whereas the Cy5-
labelled dendrimers have 243 flours per dendrimer, with
a standard error of ± 4 molecules. Recent improvements in
denrimer technology have resulted in nearly 900 fluores-
cent molecules per dendrimer. It was concluded that
labelling transcripts for detection via dendrimers is likely
a more reproducible methodology for quantitative assess-
ment of miRNAs.
Validation of microarray derived expression ratios using 
qRT-PCR
To determine the utility of the miRNA microarray to
quantitatively measure expression ratios we performed
experiments to identify differentially expressed miRNAs
in a number of brain-derived cell lines. The cell lines used
were three lines with microglial characteristics (EOC
13.31, EOC 20, C8-B4), and four lines derived from neu-
Estimates of variation introduced by dyes and technical replication by an ANOVA analysis Figure 7
Estimates of variation introduced by dyes and technical replication by an ANOVA analysis.
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roblastomas (NB41A3, SK-N-FI, IMR-32, Neuro-2a). Each
cell line was cultured and passaged in the laboratory, and
LMW RNA was isolated from a number of different pas-
sages so that four biological replicates were produced
from each line. LMW RNA was isolated from these cells
and used to produce labelled cDNA; these samples were
then hybridized to the miRNA arrays. Arrays were scanned
and the intensity values obtained were used for further
analysis. Consistently differentially expressed miRNAs
between cell lines of microglial and neuroblastoma origin
were selected by the 'significance analysis of microarrays'
(SAM) [45] two-class analysis. We identified 68 miRNAs
to be significantly differentially expressed between these
two groups of cell lines with an average fold change over
2. We picked two miRNAs whose expression differed most
significantly between the two groups of cell lines to exam-
ine more closely. The expression levels in each of the cell
lines were compared and validated using qRT-PCR (Taq-
Man®  MicroRNA Reverse Transcription Assay from
Applied Biosystems). In order to directly compare expres-
sion levels from each method we chose the Neuro-2A line
as a 'standard' for comparison, and calculated the fold
changes between this line and all the others using either,
microarray signal intensities, or qRT-PCR assay. The
results are summarised in Table 2. We show there to be a
high degree of concordance between the expression levels
calculated for each of the miRNAs by either method. MiR-
222 is expressed at significantly higher levels in cell lines
of microglial origin over those of neuroblastoma origin,
and vice versa for miR-137. Smaller changes in expression
were also picked up between individual cell lines using
both methods. As has been found previously in experi-
ments to measure differential expression in mRNAs, the
fold changes calculated by qRT-PCR are often greater than
those calculated by microarray. The validation of expres-
sion trends derived from analysis with our miRNA micro-
arrays using quantitative RT-PCR provides a high degree
of confidence in our use of these arrays to measure expres-
sion trends.
Discussion
The primary aim of this investigation was to examine tar-
get labelling methodologies that could be used for our
custom miRNA microarray that did not require labour
intensive steps such as gel purification, were sensitive and
specific, useable at high-throughput and more affordable
than multiplex RT-PCR assay. In particular, we were inter-
ested to determine whether the amplification methodol-
ogy routinely in use for mRNA profiling could be directly
applied to the study of miRNAs. It was clear from our eval-
uation that high-throughput microarray analysis of
miRNA expression could be performed accurately using
amplified targets.
Investigation of the sensitivity of detection, using a syn-
thetic miRNA and an array of matched and mismatched
probes, we found there to be an advantage in terms of sen-
sitivity of detection for low-abundance miRNAs after
amplification, in comparison to a direct labelling technol-
ogy. However, when specificity was examined on the same
platform, we found that the ability to discriminate
between closely related sequences was reduced after
amplification.
Using total brain LMW RNA as starting material for both
the direct labelling and amplification protocols we meas-
ured very similar sensitivity and specificity for both meth-
ods; a TaqMan® quantitative RT-PCR method was used as
the 'gold standard' for validation. We concluded that the
reduction in specificity after amplification resulted in high
non-specific signal intensities across the array, which
masked detection of low abundance miRNAs. It is possi-
ble that by using an amplification technique, in which
only full length targets are selectively labelled, to reduce
non-specific hybridization, the sensitivity of detection for
Table 2: Comparison of miRNA fold changes in a number of brain derived cell lines by Microarray and RT-PCR
Cell line miRNA Fold Change by Microarray Fold Change by qRT-PCR
EOC 13.31 miR-137 -9.9 -38.3
miR-222 137 4153
EOC 20 miR-137 -1.7 -19.6
miR-222 113 290
C8-B4 miR-137 -3.5 -10.7
miR-222 17.9 102
NB41A3 miR-137 1.01 -3.7
miR-222 ND 13.9
SK-N-FI miR-137 11.1 11.4
miR-222 ND 1.3
IMR-32 miR-137 -2.0 1.04
miR-222 1.7 12.1
The fold change in expression was determined for six brain derived cell lines in comparison with their expression in the cell line N2a.
ND – miRNA was not detected using this methodologyBMC Biotechnology 2006, 6:47 http://www.biomedcentral.com/1472-6750/6/47
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methods including amplification could be increased;
potentially this increase in sensitivity could bring the
range of detection for microarrays to a value similar to the
10 amoles detection limit that was observed for the qRT-
PCR assay, and a requirement for μg rather than mg quan-
tities of starting material. In this case, PCR amplification
of reverse transcription products prior to linear amplifica-
tion to select for full-length transcripts may be the solu-
tion to these problems [27]. Initially, this would require
the ligation of specific adapters to both the 3' and 5' ends
of the mature miRNAs and the use of adapter specific
primers for the PCR reactions [27].
It is worth noting at this point, a new addition to microar-
ray based analysis of miRNAs; the RNA-primed array-
based Klenow enzyme (RAKE) assays [46]. In this tech-
nique, antisense DNA oligonucleotide sequences are used
to probe for miRNAs and upon binding miRNAs serve as
primers for Klenow enzyme based extension. During the
generation of the double stranded fragment, tagged nucle-
otides are incorporated allowing for easy detection. The
advantage of this method is that it does not require the
manipulation of the initial RNA investment and also does
not require the generation of a cDNA library or amplifica-
tion. Most laboratories, however, have custom microarray
platforms with optimized target labelling protocols and
hopefully our results will alert those researchers in the
field to possible areas of misinterpretation.
Lastly, we anticipate and encourage discussion about all
aspects of microarray analysis of miRNAs, not only in the
area of labelling but also in other areas of the technology
where there is possibility for the introduction of system-
atic bias. High-throughput techniques in the analysis of
miRNAs, such as microarrays, will be helpful to further
understand the role(s) of miRNAs in normal and diseased
cells and tissues.
Conclusion
For high-throughput analysis of limited amounts of miR-
NAs by microarrays we show that linear amplification of
LMW RNA targets does not significantly increase the sen-
sitivity of low abundance miRNAs, in comparison to
direct-labelled targets. Additionally, the amplified targets
also showed decreased probe specificity and increased var-
iation introduced by dye bias.
Methods
MiRNA microarray construction
A microarray containing oligonucleotide probes compli-
mentary to 557 miRNAs was constructed. These probes
consisted of all the non-redundant miRNA sequences
from the miRNA registry (Release 5.0) [37]. The arrays
were spotted in-house on Corning® epoxide coated slides;
Probes were spotted in duplicate and additionally two full
arrays were printed per slide. The probes were in sense ori-
entation relative to the mature miRNAs and thus compli-
mentary to either the cDNA or aRNA that would be
derived from the mature miRNAs. The probes also had a
15 nucleotide long poly(T) tract at the 5'end for steric dis-
tancing from the array surface. Each probe was printed in
duplicate and the signal intensities for averaged.
Low molecular weight RNA enrichment
Low molecular weight (LMW) RNA enrichment from
whole mouse brain was performed using mirVana™
miRNA Isolation Kit (Ambion), according to the manu-
facturer's protocol. LMW RNA was DNase-treated for
microarray target preparation using TURBO DNA-free™
(Ambion). Chemically synthesized miRNAs were pur-
chased from Dharmacon.
Preparation of labelled-cDNA targets
Array 900 miRNA RT Kit (Genisphere) was used to pre-
pare labelled cDNA targets for microarray hybridization
according to the manufacturer's protocol. Briefly, 250 ng
of LMW enriched RNA was used as a template in a 100 μl
Poly(A) Tailing and RT reaction containing 1× Reaction
Mix, 2.5 mM MnCl2, 1 mM ATP, and 4 μL poly A polymer-
ase (E-PAP Enzyme). After incubation at 37°C for 15 min-
utes the reaction was placed on ice and 2 μL of Cy3 or Cy5
reverse transcriptase primer was added. The reaction mix
was incubated at 65°C for 10 minutes prior to addition of
23 μL of a second master mix containing per reaction: 10
μL of 5× First Strand Buffer, 5 μL of 0.1 M DTT, 2.5 μL of
dNTP Mix, 1 μL of Superase-in RNase Inhibitor, 2 μL of
SuperScript II Reverse Transcriptase (200 U) (Invitrogen),
and 2.5 μL of nuclease-free water. Subsequently, the reac-
tion was incubated at 42°C for one hour. Finally, 8.75 μL
of 0.5 M NaOH/50 mM EDTA and 65°C for 15 minutes
was used to inactivate Superscript II. Samples were con-
centrated to a volume of approximately 10–15 μL, using
Microcon YM-10 Centrifugal Filter Devices (Fisher Scien-
tific) according to the manufacturer's protocol.
Preparation of labelled-aRNA targets
LMW enriched RNA was polyadenylated using the
Poly(A) Tailing Kit (Ambion); 250 ng of LMW enriched
RNA was used as a template for a 25 μl Poly(A) Tailing
reaction containing 1× Reaction Mix, 2.5 mM MnCl2, 1
mM ATP, and 1 μL poly(A) polymerase (PAP Enzyme).
The reaction was placed on ice. For differential labelling of
targets, approximately 100 ng of polyadenylated LMW
RNA was mixed with 1 μL of T7 Oligo(dT) Primer, and
nuclease-free water added to 12 μL. After incubation at
70°C for 10 minutes 8 μL of a reverse transcription mix-
ture was added, 2 μL of 10 × First Strand Buffer, 1 μL Ribo-
nuclease Inhibitor, 4 μL dNTP Mix, and 1 μL of Reverse
Transcriptase, and incubation continued at 42°C for 2
hours. Following this 80 μL of second strand synthesisBMC Biotechnology 2006, 6:47 http://www.biomedcentral.com/1472-6750/6/47
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buffer was added, which included 1× Second Strand
Buffer, 4 μL of dNTP Mix, 2 μL of DNA polymerase, and 1
μL of RNase H, and the sample incubated at 16°C for 2
hours. Newly synthesized cDNA was purified using cDNA
Filter Cartridges and used for an in vitro transcription reac-
tion to generate chemically modified aRNA. In vitro tran-
scription was performed in a 40 μL reaction including the
double stranded cDNA from the second strand synthesis,
3.75 mM aaUTP, 7.5 mM ATP, CTP, GTP Mix, 3.75 mM
UTP, 1× T7 Reaction Buffer, and 4 μL of T7 Enzyme Mix.
The mix was incubated for 14 hours at 37°C and then
treated with DNase (2 μL per reaction) for 30 minutes at
37°C to remove template cDNA. The aRNA was purified
using aRNA Filter Cartridges and the aRNA:dye coupling
reaction was performed according to the manufacturer's
protocol. Briefly, 5–20 μg of amino allyl aRNA was dried
down to a thin film in a microfuge tube and 9 μL of cou-
pling buffer, and 11 μL of either of the dyes Alexa Fluor
Succinimidyl Ester 555 or 647 constituted in DMSO (one
dye vial re-suspended in 88 μL of DMSO) (Invitrogen),
were added. After incubating at room temperature for 30
minutes in the dark, 4.5 μL of 4 M hydroxylamine was
added to quench the amine-reactive groups of the unre-
acted dye molecules. After incubation for 15 minutes at
room temperature the labelled amino allyl aRNA was
purified using aRNA filter cartridges.
Target hybridization to microarray
Tagged-cDNA hybridization followed the protocol out-
lined in the 900 miRNA RT Kit. A hybridization mixture
consisting of the differentially tagged cDNA (10 μL of
Cy3-labelled and 10 μL of Cy5-labelled targets) and 2 ×
SDS-based Hybridization Buffer pre-heated to 70°C (20
μL) was mixed and incubated at 75–80°C for 10 minutes,
cooled to 50°C until loading and added to the microar-
ray; specifically a 22 × 40 mm cover slip (mSeries Lifter-
slip™) (Erie Scientific) was centered over the grids and the
preheated hybridization mixture was loaded under the
cover slip. Microarrays were incubated overnight (16–20
hours) at 50°C in a dark humidified chamber (Genetix).
Following hybridisation the cover-slips were removed and
the arrays were washed in 2 × SSC, 0.2% SDS wash buffer
preheated to 42°C for 15 minutes, 2 × SSC wash buffer at
room temperature for 10–15 minutes, and 0.2 × SSC wash
buffer at room temperature for 10–15 minutes. Arrays
were dried by centrifugation at 1000 rpm for 2–3 minutes
and the 3DNA system containing the fluorescent cyanine
molecules were hybridized to the arrays; in this case the
hybridization mixture contained Cy3 3DNA Capture Rea-
gent (2.5 μL), Cy5 3DNA Capture Reagent (2.5 μL),
Nuclease Free Water (15 μL), and 2 × SDS-based Hybridi-
zation Buffer. The mix was heated to 70°C for 10 minutes,
cooled to 62–64°C and hybridized to the arrays for 4
hours at 62–64°C in a dark humidified chamber. Finally,
the arrays were washed as previously described.
Differentially labelled aRNA targets were hybridized to
the arrays according to the protocol outlined in the Amino
Allyl MessageAmp™ Kit. Since the purified labelled aRNA
was eluted in a final volume of 100 μL, it was necessary to
firstly concentrate the samples to approximately 1–5 μL
by vacuum drying in the dark. aRNA target was resus-
pended in Pronto!™ Short Oligo Hybridization Solution
(Corning) to a final volume of 20 μL and differentially
labelled aRNA targets combined and loaded onto arrays.
Hybridized arrays were incubated for 16 hours at 50°C in
a dark humidified chamber. Upon incubation, the slides
were washed in 2 × SSC, 0.1% SDS pre-warmed to 42°C
for 5 minutes, twice in 1 × SSC wash buffer at room tem-
perature for 2 minutes, and two successive washes in 0.1
× SSC at room temperature for one minute each time. The
arrays were dried by centrifugation at 1000 rpm for 2–3
minutes.
Microarray spot quantification and analysis
Microarrays were scanned using Agilent G2565AA and
Agilent G2565BA Microarray Scanner System (Agilent).
Feature extraction was performed using Array-Pro™ ana-
lyzer version 4.5 (Media Cybernetics). The intensities of
duplicate spots on each array were averaged. Partek® soft-
ware, version 6.2 Copyright© 2006 (Partek) was used to
perform ANOVAs.
qRT-PCR (TaqMam® MiRNA Assays)
Reverse transcriptase reactions were performed using the
TaqMan® MicroRNA Reverse Transcription Kit (Applied
Biosystems). Each reaction contained 20 ng LMW
enriched RNA, 1 mM dNTPs (with dTTP), 1 μL of 3.3 U
MultiScribe™ Reverse Transcriptase, 1× Reverse Transcrip-
tion Buffer, 3.75 U RNase Inhibitor, and 3 μL of RT
primer. The reaction was carried out at 16°C for 30 min-
utes, 42°C for 30 minutes, and 85°C for 5 minutes. Semi-
quantitative PCR reactions were performed according to
the methodology outlined in the TaqMan® MiRNA Assay
Kit (Applied Biosystems). Briefly, each reaction contained
TaqMan 1× Universal PCR Master Mix (No AmpErase
UNG), 1× TaqMan® MicroRNA Assay Mix, and 1.33 μL of
the RT product in a total volume of 20 μL. Each reaction
was incubated in an Applied Biosystems 7500 Real Time
PCR System in a 96-well plate at 95°C for 10 minutes, fol-
lowed by 40 cycles of 95°C for 15 sec and 60°C for 1
minute. The threshold cycle (Ct) method was used to
determine the relative quantities of each miRNA, and was
defined as the fractional cycle number at which the fluo-
rescence passes the fixed threshold.
To determine the fold changes in expression between
miRNAs in a number of cell lines we used the following
methodology. The expression of each miRNA relative to
let-7a was determined using the ΔΔCt method. Average
fold differences for each miRNA were calculated by com-BMC Biotechnology 2006, 6:47 http://www.biomedcentral.com/1472-6750/6/47
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paring the relative expression (ΔΔCt values) in each of the
cell lines tested in comparison to a standard (ΔΔCt values
were compared for each cell line EOC 13.31, EOC 20, C8-
B4, NB41A3, SK-N-FI, IMR-32 with the ΔΔCt value for
Neuro-2a). All experiments were performed in triplicate.
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